Online citations, reference lists, and bibliographies.
← Back to Search

Prevention Of Post-ERCP Pancreatitis: A Comprehensive Review.

M. Freeman, N. Guda
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1056/NEJM199609263351302
Gabexate mesilate for the prevention of acute pancreatitis following endoscopic retrograde cholangiopancreatography.
G. Cavallini (1996)
10.1016/S0016-5107(99)70157-4
Selective cannulation of the common bile duct: a prospective randomized trial comparing standard catheters with sphincterotomes.
G. A. Cortas (1999)
Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes.
K. Gottlieb (1996)
10.1055/S-2003-42614
Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.
E. Masci (2003)
10.1067/MGE.2001.116564
Endoscopic management of tumors of the major duodenal papilla: Refined techniques to improve outcome and avoid complications.
D. Desilets (2001)
10.1016/S0016-5107(02)70112-0
Risk factors for complications after performance of ERCP.
J. Vandervoort (2002)
10.1055/S-2007-1005476
Needle-knife sphincterotomy as a precut procedure: a retrospective evaluation of efficacy and complications.
W. Bruins Slot (1996)
10.1016/S0016-5107(96)70163-3
Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy.
M. Smith (1996)
10.1136/gut.31.7.821
Pancreatitis after sphincter of Oddi manometry.
P. Rolny (1990)
10.1016/S0016-5107(95)90002-0
The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
R. Arcidiacono (1994)
10.1016/S0140-6736(96)11026-6
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones
J. Bergman (1997)
10.1016/S0016-5107(96)70164-5
Stent-induced pancreatic ductal and parenchymal changes: correlation of endoscopic ultrasound with ERCP.
S. Sherman (1996)
10.1016/S0016-5107(99)70385-8
Same-day discharge after endoscopic biliary sphincterotomy: observations from a prospective multicenter complication study. The Multicenter Endoscopic Sphincterotomy (MESH) Study Group.
M. Freeman (1999)
10.1016/S0016-5107(98)70320-7
Endoscopic pancreatic sphincterotomy: indications, outcome, and a safe stentless technique.
E. Elton (1998)
10.1016/S0016-5107(98)70121-X
Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.
S. Loperfido (1998)
10.1046/J.0007-1323.2001.01842.X
Prospective randomized double‐blind placebo‐controlled trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography‐induced pancreatitis
S. Sudhindran (2001)
10.1097/00000658-199802000-00008
Endoscopic sphincterotomy for stones by experts is safe, even in younger patients with normal ducts.
P. Cotton (1998)
10.1055/S-2002-23630
Post-ERCP pancreatitis and hyperamylasemia: patient-related and operative risk factors.
E. Christoforidis (2002)
10.1016/S0002-9270(01)02655-7
A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis
J. Dumot (2001)
10.1055/S-2007-1010650
Endoscopic management of pancreatic disorders: potential risks of pancreatic prostheses.
J. Siegel (1991)
10.1055/S-2007-1001281
A new HF current generator with automatically controlled system (Endocut mode) for endoscopic sphincterotomy--preliminary experience.
A. Kohler (1998)
10.1016/S0016-5107(96)70053-6
Papillary roof incision using the Erlangen-type pre-cut papillotome to achieve selective bile duct cannulation.
K. Binmoeller (1996)
10.1016/S0016-5107(02)70184-3
Safety and outcome of endoscopic snare excision of the major duodenal papilla.
I. Norton (2002)
10.1097/00006676-199607000-00008
Long‐Term Prophylactic Administration of Octreotide Reduces the Rise in Serum Amylase After Endoscopic Procedures on Vater's Papilla
P. Testoni (1996)
10.1016/S0016-5107(92)70429-5
Incidence and risk factors for biliary and pancreatic stent migration.
J. Johanson (1992)
10.1067/MGE.2003.56
Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial
N. Fujita (2003)
10.1016/S0016-5107(00)14046-5
3346 Evaluation of recombinant human plateletactivating factor acetylhydrolase (rpaf-ah) for reducing the incidence and severity of post-ercp acute pancreatitis (ap).
S. Sherman (2000)
10.1055/S-2001-17918
First cut, then blend: an electrocautery technique affecting bleeding at sphincterotomy.
A. Gorelick (2001)
10.1016/S0016-5107(95)70272-5
A prospective assessment of results for needle-knife papillotomy and standard endoscopic sphincterotomy.
P. Foutch (1995)
10.1016/S0016-5107(03)02540-9
The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis.
Jeremy J. Schwartz (2004)
10.1007/BF01296438
Effect of somatostatin analog octreotide on human sphincter of Oddi
K. Binmoeller (2005)
10.1016/S0016-5107(00)70402-0
Prevention of post-ERCP pancreatitis.
G. Haber (2000)
10.1055/S-2007-1013022
Iopamidol as contrast medium in endoscopic retrograde pancreatography: a prospective randomised comparison with diatrizoate.
H. J. O'Connor (1988)
10.1046/j.1440-1746.1999.01798.x
Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones
Y. Ochi (1999)
10.1067/MGE.2003.124
Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.
A. Fazel (2003)
10.1067/MGE.2002.122614
Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.
S. Manolakopoulos (2002)
10.1067/MGE.2003.61
A comparative study of postendoscopic sphincterotomy complications with various types of electrosurgical current in patients with choledocholithiasis.
G. Stefanidis (2003)
10.1016/S0002-9270(02)04185-0
An assessment of the learning curve for precut biliary sphincterotomy
G. Harewood (2002)
Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction.
Y. Chen (1994)
10.1159/000201021
Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.
J. A. Sand (1993)
10.1067/MGE.2003.307
Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.
S. Sherman (2003)
10.1046/J.1440-1622.2000.01964.X
What are the risks of diagnostic and therapeutic endoscopic retrograde cholangiopancreatography?
G. Tzovaras (2000)
10.1055/S-2007-1001308
Predictors of post-ERCP complications in patients with suspected choledocholithiasis.
S. Mehta (1998)
10.1055/S-2003-41576
Prospective randomized pilot trial of selective biliary cannulation using pancreatic guide-wire placement.
S. Maeda (2003)
10.1016/S0016-5107(97)70301-8
Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis?
P. Tarnasky (1997)
10.1097/00004836-199610000-00004
Needle knife papillotomy in a university referral practice. Safety and efficacy of a modified technique.
C. Gholson (1996)
10.1136/gut.52.8.1165
Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial
P. Vlavianos (2003)
10.1016/S0016-5107(97)70089-0
Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group.
G. K. Johnson (1997)
10.1055/S-2007-1013018
A randomised, prospective study comparing two contrast media in ERCP.
W. Cunliffe (1987)
10.1016/S0016-5107(85)72018-4
Hyperamylasemia after ERCP with ionic and non-ionic contrast media.
B. Hannigan (1985)
10.1016/S0016-5107(95)70128-1
A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group.
G. K. Johnson (1995)
10.1136/gut.33.8.1129
Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
K. Binmoeller (1992)
10.1016/S0016-5107(99)70045-3
Pancreatitis induced by endoscopic balloon sphincter dilation and changes in serum amylase levels after the procedure.
N. Ueno (1999)
10.1016/S0016-5107(97)70087-7
Benefits and risks of needle-knife papillotomy.
T. Rabenstein (1997)
10.1016/S0016-5107(90)70958-3
Pancreatic stents can induce ductal changes consistent with chronic pancreatitis.
R. Kozarek (1990)
10.1055/S-2003-39677
Reduced risk for pancreatitis after endoscopic microtransducer manometry of the sphincter of Oddi: a randomized comparison with the perfusion manometry technique.
T. Wehrmann (2003)
Can somatostatin prevent injection pancreatitis after ERCP?
B. Persson (1992)
A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
J. Sternlieb (1992)
10.1016/S0016-5107(00)70377-4
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.
A. Andriulli (2000)
10.1016/S0016-5107(98)70348-7
Pure cut electrocautery current for sphincterotomy causes less post-procedure pancreatitis than blended current.
G. Elta (1998)
10.1055/S-2007-1005482
Needle-knife access papillotomy: an unfairly maligned technique?
J. Vandervoort (1996)
An Experimental and Clinical Study
R. Berger (1966)
10.1055/S-2003-41515
Comparison of standard and steerable catheters for bile duct cannulation in ERCP.
H-U Laasch (2003)
ERCP and biliary endoscopic sphincterotomy-induced pancreatitis.
K. Gottlieb (1998)
10.1016/S0016-5107(96)70228-6
Needle-knife sphincterotomy in a tertiary referral center: efficacy and complications.
F. Kasmin (1996)
10.1016/S0016-5107(02)70178-8
Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study.
F. Prat (2002)
10.1016/S0016-5107(04)00159-2
Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
T. Rabenstein (2004)
10.1111/j.1572-0241.1999.00864.x
Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM)
M. Maldonado (1999)
10.1055/s-1999-13659
Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals.
R. Trap (1999)
Controlled trial of different dosages of octreotide in the prevention of hyperamylasemia induced by endoscopic papillosphincterotomy.
P. Testoni (1994)
10.1016/S0002-9270(00)02387-X
Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.
E. Masci (2001)
10.1055/S-2002-23629
Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.
E. Fogel (2002)
10.1067/MGE.2000.107909
A sphincterotome-based technique for selective transpapillary common bile duct cannulation.
H. Schwacha (2000)
10.1016/S0016-5107(05)80487-0
Underestimation of adverse events following ERCP: A prospective 30 day follow-up study
Mk Newcomer (1995)
10.1046/j.1365-2036.2001.01015.x
Octreotide 24‐h prophylaxis in patients at high risk for post‐ERCP pancreatitis: results of a multicenter, randomized, controlled trial
P. Testoni (2001)
10.1016/S0016-5085(98)70031-9
Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.
P. Tarnasky (1998)
10.1016/S0002-9270(03)00704-4
Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.
E. Masci (2003)
Precut (needle knife) papillotomy for impacted common bile duct stone at the ampulla.
J. Leung (1990)
10.1016/S0016-5107(95)70052-8
Endoscopic balloon sphincteroplasty (papillary dilation) for bile duct stones: efficacy, safety, and follow-up in 100 patients.
P. M. Mathuna (1995)
10.1016/S0016-5107(99)70288-9
The effect of endoscopic sphincterotomy on acute and chronic complications of biliary endoprostheses.
C. Margulies (1999)
10.1055/S-2007-993721
Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases.
Y. Komatsu (1998)
10.1016/S0016-5107(02)70351-9
National Institutes of Health State-of-the-Science Conference Statement: ERCP for diagnosis and therapy, January 14-16, 2002.
Sidney Cohen (2002)
10.1055/S-2002-32004
Bedside scoring system to predict the risk of developing pancreatitis following ERCP.
S. Friedland (2002)
10.1111/j.1572-0241.1999.01072.x
Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis
P. Testoni (1999)
10.1067/MGE.2001.115730
Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.
T. Aizawa (2001)
10.1016/S0016-5107(02)70431-8
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
A. Andriulli (2002)
10.1111/j.1572-0241.1998.061_c.x
Pretreatment With Methylprednisolone to Prevent Ercp-Induced Pancreatitis: A Randomized, Multicenter, Placebo-Controlled Clinical Trial
J. Dumot (1998)
10.1053/GAST.1997.V112.PM9041259
Interleukin 10 reduces the severity of acute pancreatitis in rats.
A. Rongione (1997)
Needle-knife papillotomy revisited.
J. Baillie (1997)
Endoscopic papillo-sphincterotomy: Prevention of pancreatic reaction by somatostatin
P. Testoni (1988)
10.1067/MGE.2002.122616
Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?
T. Rabenstein (2002)
10.1056/NEJM199609263351301
Complications of endoscopic biliary sphincterotomy.
M. Freeman (1996)
10.1016/S0016-5107(99)80039-X
Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography.
J. Kotrlik (1999)
10.1016/0016-5085(95)90158-2
Interleukin 10 prevents necrosis in murine experimental acute pancreatitis.
J. van Laethem (1995)
10.1016/S0016-5107(98)70318-9
Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study.
J. Bordas (1998)
10.1016/S0016-5107(92)70430-1
Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter.
S. Sherman (1992)
10.1016/S0016-5107(94)70204-7
Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent.
S. Sherman (1994)
The effect of octreotide on the prevention of acute pancreatitis and hyperamylasemia after diagnostic and therapeutic ERCP.
D. Arvanitidis (1998)
10.1016/S0016-5107(91)70620-2
The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography.
Z. Tulassay (1991)
10.1055/S-2007-1001390
Needle-knife papillotomy: a helpful and safe adjunct to endoscopic retrograde cholangiopancreatography in a selected population.
C. Rollhauser (1998)
10.1378/CHEST.95.2_SUPPLEMENT.2S
Rules of evidence and clinical recommendations on the use of antithrombotic agents.
D. Sackett (1986)
10.1016/S0016-5107(03)02530-6
Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.
M. Freeman (2004)
10.1016/S0016-5107(91)70619-6
Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis.
M. Guelrud (1991)
10.1016/S0016-5107(99)80010-8
Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques.
T. Rabenstein (1999)
10.1055/S-2001-13693
Endoscopic therapy of benign tumors of the papilla of Vater.
Z. Zádorová (2001)
10.1016/S0016-5107(99)70386-X
Features that may predict hospital admission following outpatient therapeutic ERCP.
K. Ho (1999)
10.1016/S1096-2883(99)80023-0
Precut (access) sphincterotomy
M. Freeman (1999)
Prophylactic pancreatic stenting for prevention of post ercp acute pancreatitis a meta analysis of controlled trials
Pankaj Singh (2003)
10.1046/j.1365-2036.1998.00414.x
Octreotide in the prevention of pancreatic injury associated with endoscopic cholangiopancreatography
Tulassay (1998)
Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
A. Andriulli (2003)
10.1016/S1091-255X(01)80059-7
Post-ERCP pancreatitis: Reduction by routine antibiotics
S. Räty (2001)
10.1067/MGE.2003.29
Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.
M. Moretó (2003)
10.1016/0016-5085(91)90735-4
Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts.
S. Sherman (1991)
10.1055/S-2007-1008945
Endoscopic papillotomy for common bile duct stones: factors influencing the complication rate.
J. Boender (1994)
10.1055/S-2007-1004185
Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.
P. Tarnasky (1997)
10.1067/MGE.2001.117550
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.
M. Freeman (2001)
10.1111/j.1365-2362.1991.tb01374.x
Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase—antiproteinase interaction during acute pancreatitis in man
P. Toulon (1991)
10.1055/S-2000-138
Analysis of the risk factors associated with endoscopic sphincterotomy techniques: preliminary results of a prospective study, with emphasis on the reduced risk of acute pancreatitis with low-dose anticoagulation treatment.
T. Rabenstein (2000)
10.1007/BF02220440
Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones a randomized trial with manometric function
Atsushi Minami (2005)
10.1016/S0016-5107(89)72921-7
Precut papillotomy--a risky technique for experts only.
P. Cotton (1989)
10.1016/S0016-5107(93)70217-5
Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients.
A. Smithline (1993)
10.1055/S-2001-16520
A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis.
A. Budzyńska (2001)
10.1016/S0016-5107(91)70740-2
Endoscopic sphincterotomy complications and their management: an attempt at consensus.
P. Cotton (1991)
Common bile duct sphincter of Oddi stenting in patients with suspected sphincter dysfunction.
Goff Js (1995)
10.1111/j.1440-1746.2003.03297.x
Can somatostatin prevent post‐ERCP pancreatitis? Results of a randomized controlled trial
D. Arvanitidis (2004)
Where does serum amylase come from and where does it go?
C. Pieper-Bigelow (1990)
10.1016/S0016-5107(90)71115-7
Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter.
S. Sherman (1990)
10.1056/NEJM199609263351302
Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
G. Cavallini (1996)
10.1016/S0016-5085(03)00384-6
Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.
B. Murray (2003)
A prospective study of the safety of endoscopic therapy for choledocholithiasis in an outpatient population.
A. Elfant (1996)
10.1053/GAST.2001.26047
Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
J. Deviére (2001)
10.1055/S-2001-15307
Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study.
J. C. Arnold (2001)
10.1016/S0016-5107(99)80012-1
Long-term experience with the transpancreatic sphincter pre-cut approach to biliary sphincterotomy.
J. Goff (1999)
10.1111/j.1572-0241.1999.999_u.x
Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study
G. D. Palma (1999)
Bipolar versus monopolar sphincterotomy: a prospective trial.
J. Siegel (1994)
10.1016/S0016-5107(99)70387-1
Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.
R. Poon (1999)
Precut papillotomy using a needle knife: experience in 100 patients with malignant obstructive jaundice.
V. Dhir (1997)
10.1016/S0016-5107(97)80418-X
Endoscopic balloon dilation compared to sphincterotomy (EDES) for extraction of bile duct stones: Preliminary results
J. Disario (1997)
10.1159/000180981
Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy.
J. Bordas (1988)
10.1016/S0016-5107(95)70014-5
Use of corticosteroids in the prevention of post-ERCP pancreatitis.
G. R. Weiner (1995)
10.1016/S0016-5107(03)02366-6
Endoscopic management of adenoma of the major duodenal papilla.
M. Catalano (2004)
10.1016/S0016-5107(99)70008-8
Accuracy and complication rate of brush cytology from bile duct versus pancreatic duct.
J. Vandervoort (1999)
10.1016/S0016-5107(96)80486-X
Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy (ES)-induced pancreatitis? a final analysis of a randomized prospective study
S. Sherman (1996)
10.1055/S-2007-1004079
Endoscopic sphincteroclasy: a useful therapeutic tool for biliary endoscopy in Billroth II gastrectomy patients.
F. Prat (1997)



This paper is referenced by
[AGA Institute technical review on acute pancreatitis].
C. Forsmark (2007)
Risk of Post-ERCP Pancreatitis in Liver Transplant Patients: Single Center Experience
Shailender Singh (2019)
10.1016/j.gie.2010.08.022
Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction.
P. Cotton (2010)
10.3748/WJG.14.720
Double balloon endoscopy associated pancreatitis: a description of six cases.
S. Jarbandhan (2008)
Aplicación de una escala pronóstica para complicaciones postcolangiopancreatografía retrógrada endoscópica
Alan Mijail Langarica Zárate (2016)
10.1016/j.pan.2019.07.046
Peri-Procedural Aggressive Hydration for Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis Prophylaxsis: Meta-analysis of Randomized Controlled Trials.
Dhruvil Radadiya (2019)
10.1007/s11894-011-0179-7
Complications of Endoscopic and Radiologic Investigation of Biliary Tract Disorders
K. Mergener (2011)
10.1016/j.gie.2018.03.012
Stent placement by EUS or ERCP for primary biliary decompression in pancreatic cancer: a randomized trial (with videos).
J. Y. Bang (2018)
10.1055/s-0032-1326640
Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis.
F. Tse (2013)
10.14701/ahbps.2020.24.3.259
Naproxen, isosorbide dinitrate and co-administration cannot prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial
Fariborz Mansour-Ghanaei (2020)
10.1002/9781444328417.CH10
Pancreatography (Including Pancreatic Sphincterotomy and Difficult Cannulation)
N. Guda (2010)
10.1111/j.1572-0241.2007.01267.x
Isotretinoin and Inflammatory Bowel Disease
M. Guslandi (2007)
10.1111/j.1572-0241.2007.01328.x
Efficacy Versus Effectiveness of Octreotide in the Prophylaxis of Post-ERCP Pancreatitis
A. Andriulli (2007)
10.1016/J.GIE.2006.07.031
Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.
A. Das (2007)
10.1097/MPA.0b013e31817f528f
Preventive Effects of Ulinastatin on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients: A Prospective, Randomized, Placebo-Controlled Trial
J. Yoo (2008)
10.1038/ncpgasthep0654
Post-ERCP pancreatitis and its prevention
Carl D Frank (2006)
10.1016/J.GIE.2006.06.032
Suprapapillary puncture of the common bile duct for selective biliary access: a novel technique (with videos).
E. Artifon (2007)
10.1055/s-0034-1365701
5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis.
E. Afghani (2014)
10.1016/j.giec.2013.06.003
Preventing pancreatitis after endoscopic retrograde cholangiopancreatography.
Nisa M Kubiliun (2013)
10.1016/B978-1-4377-1454-8.00053-9
Chapter 53 – Etiology, pathogenesis, and diagnostic assessment of acute pancreatitis
Julia V Mayerle (2012)
10.17235/reed.2018.5652/2018
Indicadores de calidad en colangiopancreatografía retrógrada endoscópica. Procedimiento de la colangiopancreatografía retrógrada endoscópica
Fernando Alberca-de-las-Parras (2018)
Estudio clínico randomizado de indometacina rectal para profilaxis de pancreatitis post-CPRE
S. AlexRuiz (2012)
10.1097/MCG.0000000000000831
Aggressive Hydration for the Prevention of Post-ERCP Pancreatitis: Effective When Combined With Rectal NSAIDs?
Xavier J.N.M. Smeets (2019)
10.15406/ghoa.2018.09.00326
The comparison between combination of pancreatic stent and nsaid with nsaid alone in preventing post ERCP pancreatitis
Alizadeh Arash Heidarnezhad (2018)
10.1016/B978-1-4160-4271-6.50011-3
Chapter 6 – Complications of ERCP: Prediction, Prevention and Management
M. Freeman (2008)
10.1016/j.gie.2012.08.021
Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis.
Xiwei Ding (2012)
10.1007/S11938-005-0005-0
Endoscopic biliary and pancreatic sphincterotomy
M. Freeman (2005)
10.1007/s10620-011-1695-x
Prophylactic Pancreatic Stents: Does Size Matter? A Comparison of 4-Fr and 5-Fr Stents in Reference to Post-ERCP Pancreatitis and Migration Rate
Albert Pahk (2011)
10.1016/j.curtheres.2009.08.001
Effectiveness and tolerability of NSAIDs in the prophylaxis of pancreatitis after endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis.
Minghua Zheng (2009)
10.1097/MPA.0000000000000912
The Risk Factors for Moderately Severe and Severe Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis According to the Revised Atlanta Classification
E. J. Kim (2017)
10.12968/GASN.2013.11.2.45
ERCP: indications, complications and contraindications
K. Patel (2013)
Post ERCP Changes in Oxidative Stress as a Possible Cause ofPancreatitis
Moshe Shiller (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar